148 related articles for article (PubMed ID: 16445632)
21. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of MRI in the diagnosis of borderline ovarian tumors.
Takemori M; Nishimura R; Hasegawa K
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):157-61. PubMed ID: 11942907
[TBL] [Abstract][Full Text] [Related]
23. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
24. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature.
Comerci JT; Licciardi F; Bergh PA; Gregori C; Breen JL
Obstet Gynecol; 1994 Jul; 84(1):22-8. PubMed ID: 8008317
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
28. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
[TBL] [Abstract][Full Text] [Related]
29. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
30. Malignant transformation of ovarian mature cystic teratoma.
Rim SY; Kim SM; Choi HS
Int J Gynecol Cancer; 2006; 16(1):140-4. PubMed ID: 16445624
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
32. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
33. Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9: a case report and review of literature.
Choi WK; Lee DH; Cho DH; Jang KY; Kim KM
BMC Womens Health; 2019 Nov; 19(1):149. PubMed ID: 31775731
[TBL] [Abstract][Full Text] [Related]
34. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
35. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
36. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
40. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]